封面
市場調查報告書
商品編碼
1134949

更年期熱潮紅的全球市場規模調查&預測,各治療類型,各地區分析,2022-2029年

Global Menopausal Hot Flashes Market Size study & Forecast, by Treatment Type (Hormonal Treatment and Non-hormonal Treatment) and Regional Analysis, 2022-2029

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

更年期潮熱通常是由伴隨女性更年期的雌激素水平下降導致的複雜荷爾蒙調整引起的。

對更年期及其治療的認識提高以及越來越多的支持膳食補充劑益處的研究等關鍵因素正在推動市場增長。

本調查的目的是定義近年來各個細分市場和國家的市場規模,並在未來幾年預測它們的價值。本報告設計內容涵蓋調查對象國家產業的定性和定量雙方面。

此外也提供市場未來性的成長促進因素和課題等重要方面相關之詳細資訊。再加上主要企業的競爭情形和提供產品之詳細分析,並涵括利害關係者投資所需的微觀市場潛在機會。詳細的市場區隔和子區隔如下列。

各治療類型

非荷爾蒙治療

荷爾蒙治療

各地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

義大利

其他歐洲

亞太地區

中國

印度

日本

澳洲

韓國

其他亞太地區

南美

巴西

墨西哥

全球其他地區

目錄

第1章 摘要整理

  • 市場概述
  • 世界·各分類市場估計·預測,2019年~2029年
    • 更年期熱潮紅市場:各地區,2019-2029年
    • 更年期熱潮紅市場:各治療類型,2019年~2029年
  • 主要趨勢
  • 調查手法
  • 調查前提條件

第2章 更年期熱潮紅的全球市場:定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查目標範圍
    • 產業的演進
  • 調查對象年
  • 貨幣換算比率

第3章 更年期熱潮紅的世界市場力學

  • 更年期熱潮紅的市場影響分析(2019-2029年)
    • 推動市場要素
    • 市場課題
    • 市場機會

第4章 全球更年期熱潮紅市場產業分析

  • 波特的5力模式
    • 供給企業談判力
    • 買方議價能力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 波特五力分析的未來性方法(2019-2029年)
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術性
  • 投資採用模式
  • 分析師的結論·建議
  • 頂級投資機會
  • 主要成功策略

第5章 風險評估:COVID-19衝擊

  • COVID-19對產業帶來的整體影響的評估
  • COVID-19以前和COVID-19以後的市場情景

第6章 更年期熱潮紅的全球市場:各治療類型

  • 市場概述
  • 更年期發熱的全球市場:各治療類型效能-潛在力分析
  • 更年期發熱的全球市場,各治療類型估計·預測2019~2029年
  • 更年期熱潮紅市場,子區隔分析
    • 非荷爾蒙治療
    • 荷爾蒙治療

第7章:更年期熱潮紅的全球市場:各地區分析

  • 更年期熱潮紅症的全球市場:各地區市場概述
  • 北美
    • 美國
      • 各治療類型的估計·預測,2019年~2029年
    • 加拿大
  • 歐洲更年期發熱市場概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他的歐洲地區
  • 亞太地區的更年期發熱市場概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的更年期障礙發熱市場概述
    • 巴西
    • 墨西哥
  • 全球其他地區

第8章 競爭資訊

  • 頂級市場策略
  • 企業簡介
    • Bristol-Myers Squibb Company
      • 主要的資訊
      • 概要
      • 根據財務(依資料可得性)
      • 產品概要
      • 最近的開發情形
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd
    • Hisamitsu Pharmaceutical Co. Inc.
    • AstraZeneca PLC
    • Agile Therapeutics
    • Novo Nordisk Corporation
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Ferring BV

第9章 調查流程

  • 調查流程
    • 資料探勘
    • 分析
    • 市場估計
    • 驗證
    • 出版
  • 調查屬性
  • 調查前提條件

Global Menopausal Hot Flashes Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.4% over the forecast period 2022-2029. Menopausal hot flashes are often brought on by the intricate hormonal adjustments brought on by the lowering oestrogen levels as menopause occurs in women. The body feels warm because of declining levels' effects on thermoregulation. On average, the illness can persist over 7 years, and in the most severe cases, it can last up to 10 years. Although it is a normal condition, it can be brought on by factors like drinking alcohol, eating hot food, smoking, being stressed, and other things. The market growth is driven by key factors such as increasing awareness about menopause and its treatment and increasing research supporting advantages of dietary supplements.

In the United States, roughly 1.3 million women cease menstruation each year, beginning between the ages of 51 and 52, according to the February 2022 version of "Menopause (Nursing)" by Kimberly Peacock et al. About 5% of women between the ages of 40 and 45 undergo early menopause, according to the same source. The market is also expanding as a result of the growing emphasis on research aimed at the development of treatments for hot flashes. For instance, Acer Therapeutics Inc. received FDA approval for its investigational new drug (IND) application for its selective non-peptide neurokinin 3 receptors (NK3R) antagonist, ACER-801 (osanetant), for the possible treatment of induced Vasomotor Symptoms in December 2021. (iVMS). However, side Effects Associated with Hormonal Products stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Menopausal Hot Flashes Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to increased incidence of menopause and presence of a large percentage of older women in the region. However, Asia Pacific is expected to be the fastest growing region due to increased medical tourism and growing public awareness in the region.

Major market players included in this report are:

Bristol-Myers Squibb Company

Novartis AG

Teva Pharmaceutical Industries Ltd

Hisamitsu Pharmaceutical Co. Inc.

AstraZeneca PLC

Agile Therapeutics

Novo Nordisk Corporation

Pfizer Inc.

Merck & Co. Inc.

Ferring BV

Recent Developments in the Market:

  • The U.S. Food and Drug Administration received a new drug application (NDA) for fezolinetant from Astellas Pharma Inc. in June 2022. (FDA). For the treatment of mild to severe vasomotor symptoms (VMS) related to menopause, the experimental oral, nonhormonal chemical fezolinetant is appealing for approval.
  • In order to increase the number of drugs in its pipeline, Bayer, a leading global supplier of healthcare for women, purchased KaNDy Therapeutics Ltd. in August 2020. For the treatment of menopausal symptoms, KaNDy Therapeutics Ltd. has finished the Phase IIb trials of NT-814, a first-in-class, non-hormonal neurokinin-1,3 receptor antagonist.

Global Menopausal Hot Flashes Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Treatment Type, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Non-hormonal Treatment

Hormonal Treatment

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Menopausal Hot Flashes Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Menopausal Hot Flashes Market, by Treatment Type, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Menopausal Hot Flashes Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Menopausal Hot Flashes Market Dynamics

  • 3.1. Menopausal Hot Flashes Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing awareness about menopause and its treatment
      • 3.1.1.2. Increasing research supporting advantages of dietary supplements
    • 3.1.2. Market Challenges
      • 3.1.2.1. Availability of Generic Medicines
      • 3.1.2.2. Side Effects Associated with Hormonal Products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Development of advanced products

Chapter 4. Global Menopausal Hot Flashes Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Menopausal Hot Flashes Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Menopausal Hot Flashes Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Menopausal Hot Flashes Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
  • 6.4. Menopausal Hot Flashes Market, Sub Segment Analysis
    • 6.4.1. Non-hormonal Treatment
    • 6.4.2. Hormonal Treatment

Chapter 7. Global Menopausal Hot Flashes Market, Regional Analysis

  • 7.1. Menopausal Hot Flashes Market, Regional Market Snapshot
  • 7.2. North America Menopausal Hot Flashes Market
    • 7.2.1. U.S. Menopausal Hot Flashes Market
      • 7.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Menopausal Hot Flashes Market
  • 7.3. Europe Menopausal Hot Flashes Market Snapshot
    • 7.3.1. U.K. Menopausal Hot Flashes Market
    • 7.3.2. Germany Menopausal Hot Flashes Market
    • 7.3.3. France Menopausal Hot Flashes Market
    • 7.3.4. Spain Menopausal Hot Flashes Market
    • 7.3.5. Italy Menopausal Hot Flashes Market
    • 7.3.6. Rest of Europe Menopausal Hot Flashes Market
  • 7.4. Asia-Pacific Menopausal Hot Flashes Market Snapshot
    • 7.4.1. China Menopausal Hot Flashes Market
    • 7.4.2. India Menopausal Hot Flashes Market
    • 7.4.3. Japan Menopausal Hot Flashes Market
    • 7.4.4. Australia Menopausal Hot Flashes Market
    • 7.4.5. South Korea Menopausal Hot Flashes Market
    • 7.4.6. Rest of Asia Pacific Menopausal Hot Flashes Market
  • 7.5. Latin America Menopausal Hot Flashes Market Snapshot
    • 7.5.1. Brazil Menopausal Hot Flashes Market
    • 7.5.2. Mexico Menopausal Hot Flashes Market
  • 7.6. Rest of The World Menopausal Hot Flashes Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Bristol-Myers Squibb Company
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Novartis AG
    • 8.2.3. Teva Pharmaceutical Industries Ltd
    • 8.2.4. Hisamitsu Pharmaceutical Co. Inc.
    • 8.2.5. AstraZeneca PLC
    • 8.2.6. Agile Therapeutics
    • 8.2.7. Novo Nordisk Corporation
    • 8.2.8. Pfizer Inc.
    • 8.2.9. Merck & Co. Inc.
    • 8.2.10. Ferring BV

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Menopausal Hot Flashes Market, report scope
  • TABLE 2. Global Menopausal Hot Flashes Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Menopausal Hot Flashes Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
  • TABLE 4. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Menopausal Hot Flashes Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Menopausal Hot Flashes Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Menopausal Hot Flashes Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Menopausal Hot Flashes Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Menopausal Hot Flashes Market
  • TABLE 69. List of primary sources, used in the study of global Menopausal Hot Flashes Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Menopausal Hot Flashes Market, research methodology
  • FIG 2. Global Menopausal Hot Flashes Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Menopausal Hot Flashes Market, key trends 2021
  • FIG 5. Global Menopausal Hot Flashes Market, growth prospects 2022-2029
  • FIG 6. Global Menopausal Hot Flashes Market, porters 5 force model
  • FIG 7. Global Menopausal Hot Flashes Market, pest analysis
  • FIG 8. Global Menopausal Hot Flashes Market, value chain analysis
  • FIG 9. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Menopausal Hot Flashes Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Menopausal Hot Flashes Market, regional snapshot 2019 & 2029
  • FIG 15. North America Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Menopausal Hot Flashes Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Menopausal Hot Flashes Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable